企业价值与息税折旧摊销前利润之比。较低可能意味着低估。
共 90 家公司有EV/EBITDA数据。
先确认商业模式、利润率、资本结构和当前估值倍数，避免只看单一排名就下结论。
倍数看起来便宜，不代表折现率合理。先验证资本成本，再决定 DCF 假设。
用同一家公司对应的 DCF 页面验证合理价值区间，避免排名、倍数和现金流假设互相脱节。
数据每日更新 · 来源: SEC EDGAR, Polygon.io
| UHG |
| $69M |
| 2.1 |
| 3 | VNO | $5.3B | 3.8 |
| 4 | SDHC | $124M | 4.1 |
| 5 | BFS | $835M | 5.0 |
| 6 | SQFT | $5M | 5.5 |
| 7 | TPH | $4.0B | 5.8 |
| 8 | ELME | $191M | 5.9 |
| 9 | RMAX | $119M | 6.1 |
| 10 | GRBK | $2.9B | 6.4 |
| 11 | CUZ | $3.9B | 6.6 |
| 12 | AHT | $19M | 6.9 |
| 13 | AXR | $150M | 7.1 |
| 14 | PHM | $23.5B | 7.1 |
| 15 | LOAN | $53M | 7.6 |
| 16 | CXW | $2.0B | 8.9 |
| 17 | CBL | $1.3B | 9.8 |
| 18 | ABR | $1.5B | 9.9 |
| 19 | NMRK | $2.9B | 10.0 |
| 20 | KRG | $5.2B | 10.1 |
| 21 | CCS | $1.8B | 10.3 |
| 22 | NNN | $8.4B | 10.4 |
| 23 | LXP | $2.9B | 11.0 |
| 24 | BDN | $479M | 11.2 |
| 25 | HST | $14.4B | 11.2 |
| 26 | CSR | $1.0B | 11.5 |
| 27 | JLL | $15.4B | 11.6 |
| 28 | IVT | $2.5B | 11.9 |
| 29 | CWK | $3.3B | 12.1 |
| 30 | RHP | $6.4B | 12.4 |
| 31 | NEN | $207M | 12.4 |
| 32 | REG | $14.6B | 12.6 |
| 33 | CMCT | $21M | 12.6 |
| 34 | CPT | $10.7B | 12.8 |
| 35 | CTO | $643M | 12.9 |
| 36 | EQR | $23.2B | 13.1 |
| 37 | WPC | $15.7B | 13.1 |
| 38 | VICI | $30.3B | 13.2 |
| 39 | SVC | $861M | 13.6 |
| 40 | UDR | $11.5B | 13.8 |
| 41 | PDM | $933M | 14.0 |
| 42 | BXMT | $3.4B | 14.5 |
| 43 | DOC | $11.7B | 14.6 |
| 44 | AVB | $23.8B | 14.7 |
| 45 | FRT | $9.5B | 14.8 |
| 46 | UHT | $598M | 14.9 |
| 47 | CDP | $3.7B | 15.0 |
| 48 | WSR | $972M | 15.1 |
| 49 | KIM | $15.9B | 15.2 |
| 50 | OHI | $13.5B | 15.4 |
| 51 | LAMR | $13.7B | 15.5 |
| 52 | SELF | $61M | 15.6 |
| 53 | LTC | $1.9B | 15.6 |
| 54 | LHAI | $19M | 15.8 |
| 55 | GTY | $2.0B | 15.9 |
| 56 | MAA | $14.7B | 15.9 |
| 57 | EPR | $4.3B | 16.1 |
| 58 | SAFE | $1.1B | 17.1 |
| 59 | AKR | $2.7B | 17.2 |
| 60 | BEEP | $90M | 18.0 |
| 61 | TCI | $354M | 18.5 |
| 62 | O | $59.5B | 18.8 |
| 63 | AMT | $82.3B | 19.2 |
| 64 | PSA | $53.4B | 19.5 |
| 65 | WY | $17.9B | 19.6 |
| 66 | CBRE | $43.1B | 19.6 |
| 67 | SUI | $16.0B | 20.0 |
| 68 | INTG | $77M | 20.3 |
| 69 | SPG | $65.9B | 20.4 |
| 70 | FRPH | $422M | 20.6 |
| 71 | ELS | $12.5B | 21.3 |
| 72 | SBAC | $23.1B | 21.4 |
| 73 | ADC | $9.3B | 21.8 |
| 74 | MAC | $5.5B | 22.5 |
| 75 | PLD | $129.0B | 22.7 |
| 76 | VRE | $1.8B | 23.3 |
| 77 | VTR | $40.6B | 23.3 |
| 78 | JOE | $3.9B | 23.6 |
| 79 | AIV | $590M | 23.9 |
| 80 | CURB | $2.9B | 24.2 |
| 81 | IRM | $33.9B | 24.2 |
| 82 | LGIH | $938M | 24.6 |
| 83 | BOC | $370M | 25.3 |
| 84 | EQIX | $104.3B | 29.5 |
| 85 | ECG | $6.9B | 31.0 |
| 86 | DHC | $1.8B | 31.1 |
| 87 | ARL | $229M | 42.6 |
| 88 | WELL | $148.6B | 43.9 |
| 89 | MAYS | $82M | 44.9 |
| 90 | BRT | $270M | 53.3 |